Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00251849
Status:
UNKNOWN
Last Update Posted:
2008-08-21
First Post:
2005-11-09
Brief Title:
PROVIDENCE-1 Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients
Sponsor:
ActivBiotics
Organization:
ActivBiotics
Organization Data
Organization:
ActivBiotics
Class:
INDUSTRY
Study ID:
ABI-1648-022
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ActivBiotics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None